Grey Street Capital, LLC Alpha Tau Medical Ltd. Transaction History
Grey Street Capital, LLC
- $739 Billion
- Q1 2024
A detailed history of Grey Street Capital, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Grey Street Capital, LLC holds 23,323 shares of DRTS stock, worth $53,176. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,323
Previous 23,323
-0.0%
Holding current value
$53,176
Previous $70.2 Million
1.99%
% of portfolio
0.01%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.42MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY280KShares$639,4460.07% of portfolio
-
Hoyle Cohen, LLC269KShares$613,5200.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$526,0050.0% of portfolio
-
Corbin Capital Partners, L.P. New York, NY97.2KShares$221,6090.69% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$151,2230.01% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $157M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...